Featured Topics
Calendar

January 22, 2026

Quiet Period (January 22 - February 25)

February 25, 2026

FY/Q4 2025 Results / Annual Report
Press Releases
Share Price / Index
December 12, 2025
Not intended for U.S. and UK Media
Aflibercept 8 mg recommended for EU approval for third retinal indication
December 02, 2025
Bayer welcomes Solicitor General support for U.S. Supreme Court review
November 23, 2025
Bayer’s FXIa inhibitor Met Primary Efficacy and Safety Endpoints in Landmark Phase III Study in Secondary Stroke Prevention

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.